drugset / Trial / NCT02012985
Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
Phase 1/2
Completed
28 enrolled
OxThera
FP7-SME-2013 Research for the benefit of SMEs program · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if Oxalobacter formigenes is effective at lowering urinary oxalate levels in patients with primary hyperoxaluria.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxalobacter formigenes OC5 | Unknown | 1e+09 unknown | Oral |